CompletedPhase 2NCT03110770
VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
Studying Zika virus disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Julie Ledgerwood, DOVRC, NIAID, NIH
- Intervention
- VRC-ZKADNA090-00-VP(biological)
- Enrollment
- 2428 target
- Eligibility
- 15-35 years · All sexes
- Timeline
- 2017 – 2019
Study locations (17)
- QPS-Miami Research Associates, Miami, Florida, United States
- Doctors Hospital at Renaissance, Edinburg, Texas, United States
- Baylor College of Medicine, Houston, Texas, United States
- Hospital Das Clinicas Da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
- Centro de Pesquisas Clínicas Do Instituto Central Do Hospital Das Clínicas Da FMUSP, São Paulo, São Paulo, Brazil
- Clinica de la Costa Ltda, Barranquilla, Atlántico, Colombia
- Centro de Atencion y Diagnostico de Enfermedades Infecciosas, Bucaramanga, Santander Department, Colombia
- CCIM Costa Rican Center Center of Medical Research, Sociedad Anonima, San José, Los Yoses, Costa Rica
- AGA Clinical Centro de Investigaciones, Guayaquil, Guayas, Ecuador
- Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
- Instituto Conmemorativo Gorgas, Panama City, San Miguelito Province, Panama
- Asociacion Civil Selva Amazonica, Iquitos, Maynas/Loreto, Peru
- Unidad de Ensayos (UNIDEC) del Policlinico Universidad Nacional Mayor de San Marcos, Lima, Peru
- Ponce Medical School Foundation Inc./CAIMED Center, Ponce, Puerto Rico
- Fundación de Investigación de Diego, San Juan, Puerto Rico
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03110770 on ClinicalTrials.govOther trials for Zika virus disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT04398901Neurodevelopmental Outcomes in ZIKV-Exposed ChildrenChildren's National Research Institute
- ACTIVE NOT RECRUITINGPHASE3NCT03037164INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsCerus Corporation
- RECRUITINGNCT01386424Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsNational Institute of Allergy and Infectious Diseases (NIAID)